AXT INC (AXTI) Fundamental Analysis & Valuation

NASDAQ:AXTI • US00246W1036

38.89 USD
-2.87 (-6.87%)
Last: Mar 4, 2026, 03:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AXTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AXTI. AXTI was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI has a bad profitability rating. Also its financial health evaluation is rather negative. AXTI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. AXTI Profitability Analysis

1.1 Basic Checks

  • AXTI had negative earnings in the past year.
  • AXTI had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
  • AXTI had negative operating cash flow in 4 of the past 5 years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -6.88%, AXTI is not doing good in the industry: 68.70% of the companies in the same industry are doing better.
  • AXTI's Return On Equity of -12.83% is on the low side compared to the rest of the industry. AXTI is outperformed by 70.43% of its industry peers.
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROIC N/A
ROA(3y)-4.47%
ROA(5y)-0.97%
ROE(3y)-7.58%
ROE(5y)-1.78%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • With a Gross Margin value of 11.97%, AXTI is not doing good in the industry: 84.35% of the companies in the same industry are doing better.
  • AXTI's Gross Margin has declined in the last couple of years.
  • AXTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.88%
GM growth 5Y-16.71%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AXTI Health Analysis

2.1 Basic Checks

  • AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AXTI has been increased compared to 1 year ago.
  • The number of shares outstanding for AXTI has been increased compared to 5 years ago.
  • The debt/assets ratio for AXTI has been reduced compared to a year ago.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • AXTI has an Altman-Z score of 8.78. This indicates that AXTI is financially healthy and has little risk of bankruptcy at the moment.
  • AXTI's Altman-Z score of 8.78 is fine compared to the rest of the industry. AXTI outperforms 66.96% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that AXTI is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.35, AXTI is doing worse than 63.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 8.78
ROIC/WACCN/A
WACC11.06%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 1.76 indicates that AXTI should not have too much problems paying its short term obligations.
  • AXTI has a worse Current ratio (1.76) than 79.13% of its industry peers.
  • AXTI has a Quick Ratio of 1.76. This is a bad value and indicates that AXTI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of AXTI (0.85) is worse than 89.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.85
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AXTI Growth Analysis

3.1 Past

  • AXTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.33%.
  • The Revenue for AXTI has decreased by -11.11% in the past year. This is quite bad
  • AXTI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.53% yearly.
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-11.11%
Revenue growth 3Y-14.46%
Revenue growth 5Y-1.53%
Sales Q2Q%-8.22%

3.2 Future

  • Based on estimates for the next years, AXTI will show a very strong growth in Earnings Per Share. The EPS will grow by 68.18% on average per year.
  • The Revenue is expected to grow by 32.81% on average over the next years. This is a very strong growth
EPS Next Y94.9%
EPS Next 2Y68.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year35.14%
Revenue Next 2Y32.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. AXTI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AXTI. In the last year negative earnings were reported.
  • Also next year AXTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AXTI's earnings are expected to grow with 68.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.18%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXTI Dividend Analysis

5.1 Amount

  • No dividends for AXTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXTI Fundamentals: All Metrics, Ratios and Statistics

AXT INC

NASDAQ:AXTI (3/4/2026, 3:41:09 PM)

38.89

-2.87 (-6.87%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners34.36%
Inst Owner Change116.82%
Ins Owners1.85%
Ins Owner Change4.88%
Market Cap2.11B
Revenue(TTM)88.33M
Net Income(TTM)-22.98M
Analysts81.82
Price Target28.82 (-25.89%)
Short Float %11.98%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.25%
Min EPS beat(2)-14.71%
Max EPS beat(2)75.2%
EPS beat(4)1
Avg EPS beat(4)-28.28%
Min EPS beat(4)-130.68%
Max EPS beat(4)75.2%
EPS beat(8)5
Avg EPS beat(8)2.35%
EPS beat(12)8
Avg EPS beat(12)7.78%
EPS beat(16)12
Avg EPS beat(16)13.48%
Revenue beat(2)1
Avg Revenue beat(2)12.04%
Min Revenue beat(2)-10.9%
Max Revenue beat(2)34.98%
Revenue beat(4)2
Avg Revenue beat(4)6.72%
Min Revenue beat(4)-10.9%
Max Revenue beat(4)34.98%
Revenue beat(8)5
Avg Revenue beat(8)4.66%
Revenue beat(12)5
Avg Revenue beat(12)0.71%
Revenue beat(16)6
Avg Revenue beat(16)0.36%
PT rev (1m)71.21%
PT rev (3m)197.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)-450%
EPS NY rev (3m)88.87%
Revenue NQ rev (1m)-4.19%
Revenue NQ rev (3m)-12.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.32
P/FCF N/A
P/OCF N/A
P/B 11.77
P/tB 11.77
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.67
BVpS3.3
TBVpS3.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.97%
FCFM N/A
ROA(3y)-4.47%
ROA(5y)-0.97%
ROE(3y)-7.58%
ROE(5y)-1.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.88%
GM growth 5Y-16.71%
F-Score2
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.67%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 0.85
Altman-Z 8.78
F-Score2
WACC11.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y94.9%
EPS Next 2Y68.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.11%
Revenue growth 3Y-14.46%
Revenue growth 5Y-1.53%
Sales Q2Q%-8.22%
Revenue Next Year35.14%
Revenue Next 2Y32.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-99.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.2%
OCF growth 3YN/A
OCF growth 5YN/A

AXT INC / AXTI FAQ

What is the fundamental rating for AXTI stock?

ChartMill assigns a fundamental rating of 2 / 10 to AXTI.


Can you provide the valuation status for AXT INC?

ChartMill assigns a valuation rating of 1 / 10 to AXT INC (AXTI). This can be considered as Overvalued.


How profitable is AXT INC (AXTI) stock?

AXT INC (AXTI) has a profitability rating of 0 / 10.


Can you provide the financial health for AXTI stock?

The financial health rating of AXT INC (AXTI) is 3 / 10.


Can you provide the expected EPS growth for AXTI stock?

The Earnings per Share (EPS) of AXT INC (AXTI) is expected to grow by 94.9% in the next year.